In a landmarkannouncementby the US Drug Enforcement Administration ( DEA ) , scientist conducting aesculapian and scientific research could presently have increased approach to cannabis . Since 1968 only one Union agency , the National Institute on Drug Abuse ( NIDA ) , has had the required DEA license to provide researcher with marijuana from a installation based at the University of Mississippi .
Although more than30 states in the USnow have aesculapian ganja computer programme , scientist have been confine by these restrictions .
Some have debate that the NIDA ’s monopoly for so many years has slowed down scientific investigations into thebenefits of this works . Others have pick apart the quality of cannabis coming from the NIDA facility and raise questions surrounding the lustiness of studies that utilize it . Back in 2019 , researchers at the Scottsdale Research Institute filed alawsuitagainst the DEA claiming that " The quality of the cannabis from this farm — and its bringing logistics — are pathetic . Some has languished on the shelf for years . It look more like green talcum powder pulverization than medical - grade cannabis . "
Hence the indigence to increase approach by having more approved cannabis suppliers that meet the regulatory requirements to grow medical hemp for dispersion in the US . Now , things might lastly change .
" Pending final approval , DEA has determined , based on currently usable information , that a number of manufacturers ’ program to cultivate marijuana for inquiry needs in the United States seems to be consistent with applicable effectual standard and relevant law . " The DEA said in the announcement released on May 14 , 2021 .
The DEA will now continue to approve more aesculapian cannabis provider in the US , something that could end a 52 - yr federal monopoly and dilate access to aplantthat is extremely try after for research . " There ’s thousands of different cannabis variety show that all have unique chemical profiles and produce unique clinical effects , but we did n’t have access to that normal diversity,“Dr Sue Sisley , President of the United States of the Scottsdale Research Institute , toldNPR .
Although many studies have documented themedical propertiesof cannabis , much remains unknown as there are many different varieties of the plant , all with unique property . provide inquiry institutions with increased access to aesculapian cannabis , specially increased access to different assortment that come from unlike provider , would help oneself in the pursuit to understand this fascinating plant better .
